Soligenix
SNGX
#10764
Rank
ยฃ4.43 M
Marketcap
ยฃ0.30
Share price
-1.00%
Change (1 day)
-68.62%
Change (1 year)

EPS for Soligenix (SNGX)

EPS in 2025 (TTM): -ยฃ2.43

According to Soligenix's latest financial reports the company's current EPS (TTM) is -ยฃ2.45. In 2024 the company made an earnings per share (EPS) of -ยฃ3.76 an increase over its 2023 EPS that were of -ยฃ9.56.

EPS history for Soligenix from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ2.43-35.32%
2024-ยฃ3.76-60.66%
2023-ยฃ9.56-83.55%
2022-ยฃ58.1113.95%
2021-ยฃ51.00-56.03%
2020-ยฃ115.9833.33%
2019-ยฃ86.99-29.41%
2018-ยฃ123.23-41.38%
2017-ยฃ210.2224.73%
2016-ยฃ168.54-69%
2015-ยฃ543.66-6.25%
2014-ยฃ579.91-50.77%
2013-ยฃ1,17875.68%
2012-ยฃ670.5268.18%
2011-ยฃ398.69-69.86%
2010-ยฃ1,323-8.75%
2009-ยฃ1,45033.33%
2008-ยฃ1,087-57.14%
2007-ยฃ2,537-46.15%
2006-ยฃ4,71244.44%
2005-ยฃ3,262-40.7%
2004-ยฃ5,501-15.62%
2003-ยฃ6,520-25.52%
2002-ยฃ8,754-80.94%
2001-ยฃ45,926160.89%
2000-ยฃ17,603-40.57%
1999-ยฃ29,619-63.84%
1998-ยฃ81,912601.73%
1997-ยฃ11,673101.7%
1996-ยฃ5,787

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ6.60-369.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ0.99-140.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ1.93-179.00%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-ยฃ0.72-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ1.53-37.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.03-142.28%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Emergent BioSolutions
EBS
ยฃ1.06-143.52%๐Ÿ‡บ๐Ÿ‡ธ USA